# Trade Mark Journal No.2025/052 26 December 2025

## WO0000001890496 (5)

Office of origin: United States of America

Date of International Registration:3 November 2025
Date of designation in the UK: 3 November 2025

International priority date claimed: 31 October 2025 (United States of America) (99474175)

Class 5
  Pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the treatment and prevention of lysosomal storage diseases.

Denali Therapeutics Inc.

Representative: Chelseaa Larsen Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA